AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2019
Feb 8, 2019
30403_dirs_2019-02-08_f69cf570-e40a-4087-8861-fe6e5301c2de.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2019-02-06
Reporting Person: Laszlo Matthew T (SVP - Chief Customer Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-06 | Common Stock | M | 7280.0000 | $123.0900 | Acquired | 17994.0000 | Direct |
| 2019-02-06 | Common Stock | M | 3480.0000 | $135.5700 | Acquired | 21474.0000 | Direct |
| 2019-02-06 | Common Stock | S | 10585.0000 | $153.8860 | Disposed | 10889.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-06 | Stock Option (Right to Buy) | $135.5700 | M | 3480.0000 | Disposed | 2027-09-12 | Common Stock (3480.0000) | Direct |
| 2019-02-06 | Stock Option (Right to Buy) | $123.0900 | M | 7280.0000 | Disposed | 2026-09-13 | Common Stock (7280.0000) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $153.66 to $154.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
More from CLOROX CO /DE/
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Mar 26